Open AccessA Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis
Author(s) -
Adelaide A. Hebert,
Debbie Glaab,
Rhonda Schreiber
Publication year - 2019
Publication title -
skin
Language(s) - English
Resource type - Journals
ISSN - 2574-1624
DOI - 10.25251/skin.3.2.11
Subject(s) - tolerability , plaque psoriasis , pharmacokinetics , medicine , pharmacodynamics , pharmacology , open label , psoriasis , adverse effect , dermatology
Abstract not available. Disclosures: Study sponsored by Mayne Pharma.